198 related articles for article (PubMed ID: 36087871)
1. Copper-olsalazine metal-organic frameworks as a nanocatalyst and epigenetic modulator for efficient inhibition of colorectal cancer growth and metastasis.
Li J; Zhang Z; Li J; Cun JE; Pan Q; Gao W; Luo K; He B; Gu Z; Pu Y
Acta Biomater; 2022 Oct; 152():495-506. PubMed ID: 36087871
[TBL] [Abstract][Full Text] [Related]
2. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.
Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B
Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem.
Zhang K; Meng X; Yang Z; Dong H; Zhang X
Biomaterials; 2020 Nov; 258():120278. PubMed ID: 32781328
[TBL] [Abstract][Full Text] [Related]
4. Emerging advances and current applications of nanoMOF-based membranes for water treatment.
Attia MS; Youssef AO; Abou-Omar MN; Mohamed EH; Boukherroub R; Khan A; Altalhi T; Amin MA
Chemosphere; 2022 Apr; 292():133369. PubMed ID: 34953879
[TBL] [Abstract][Full Text] [Related]
5. Different Dimensional Copper-Based Metal-Organic Frameworks with Enzyme-Mimetic Activity for Antibacterial Therapy.
Lin C; Guo X; Mo F; Sun D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834604
[TBL] [Abstract][Full Text] [Related]
6. Copper-based metal-organic frameworks for biomedical applications.
Cun JE; Fan X; Pan Q; Gao W; Luo K; He B; Pu Y
Adv Colloid Interface Sci; 2022 Jul; 305():102686. PubMed ID: 35523098
[TBL] [Abstract][Full Text] [Related]
7. Engineering 2D Cu-composed metal-organic framework nanosheets for augmented nanocatalytic tumor therapy.
Zhuang S; Xiang H; Chen Y; Wang L; Chen Y; Zhang J
J Nanobiotechnology; 2022 Feb; 20(1):66. PubMed ID: 35120548
[TBL] [Abstract][Full Text] [Related]
8. Ti-Based nanoMOF as an Efficient Oral Therapeutic Agent.
Rojas S; Guillou N; Horcajada P
ACS Appl Mater Interfaces; 2019 Jun; 11(25):22188-22193. PubMed ID: 31140777
[TBL] [Abstract][Full Text] [Related]
9. Olsalazine-Based Metal-Organic Frameworks as Biocompatible Platforms for H2 Adsorption and Drug Delivery.
Levine DJ; Runčevski T; Kapelewski MT; Keitz BK; Oktawiec J; Reed DA; Mason JA; Jiang HZ; Colwell KA; Legendre CM; FitzGerald SA; Long JR
J Am Chem Soc; 2016 Aug; 138(32):10143-50. PubMed ID: 27486905
[TBL] [Abstract][Full Text] [Related]
10. Heparin-Coated Photosensitive Metal-Organic Frameworks as Drug Delivery Nanoplatforms of Autophagy Inhibitors for Sensitized Photodynamic Therapy against Breast Cancer.
Sun Q; Hou X; Yang J; Zhang M; Yang Y; Liu Y; Shen W; Yin D
ACS Appl Mater Interfaces; 2021 Nov; 13(46):55577-55590. PubMed ID: 34762394
[TBL] [Abstract][Full Text] [Related]
11. Pushing the Limits on the Intestinal Crossing of Metal-Organic Frameworks: An
Rojas S; Hidalgo T; Luo Z; Ávila D; Laromaine A; Horcajada P
ACS Nano; 2022 Apr; 16(4):5830-5838. PubMed ID: 35298121
[TBL] [Abstract][Full Text] [Related]
12. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
Yang B; Shen M; Liu J; Ren F
Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
[TBL] [Abstract][Full Text] [Related]
13. A Cu-Based Metal-Organic Framework Cu-Cip with Cuproptosis for Cancer Therapy and Inhibition of Cancer Cell Migration.
Lu W; Lei C; Chen K; Wang Z; Liu F; Li X; Shen J; Shen Q; Gao J; Lin W; Hu Q
Inorg Chem; 2023 Dec; 62(51):21299-21308. PubMed ID: 38069807
[TBL] [Abstract][Full Text] [Related]
14. MOF × Biopolymer: Collaborative Combination of Metal-Organic Framework and Biopolymer for Advanced Anticancer Therapy.
Kim K; Lee S; Jin E; Palanikumar L; Lee JH; Kim JC; Nam JS; Jana B; Kwon TH; Kwak SK; Choe W; Ryu JH
ACS Appl Mater Interfaces; 2019 Aug; 11(31):27512-27520. PubMed ID: 31293157
[TBL] [Abstract][Full Text] [Related]
15. Furin-mediated intracellular self-assembly of olsalazine nanoparticles for enhanced magnetic resonance imaging and tumour therapy.
Yuan Y; Zhang J; Qi X; Li S; Liu G; Siddhanta S; Barman I; Song X; McMahon MT; Bulte JWM
Nat Mater; 2019 Dec; 18(12):1376-1383. PubMed ID: 31636420
[TBL] [Abstract][Full Text] [Related]
16. A "green" strategy to construct non-covalent, stable and bioactive coatings on porous MOF nanoparticles.
Agostoni V; Horcajada P; Noiray M; Malanga M; Aykaç A; Jicsinszky L; Vargas-Berenguel A; Semiramoth N; Daoud-Mahammed S; Nicolas V; Martineau C; Taulelle F; Vigneron J; Etcheberry A; Serre C; Gref R
Sci Rep; 2015 Jan; 5():7925. PubMed ID: 25603994
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-Adapted Sono-chemodynamic Treatment of Orthotopic Pancreatic Carcinoma Using Copper Metal-Organic Frameworks Loaded with an Ultrasound-Induced Free Radical Initiator.
Sun Y; Cao J; Wang X; Zhang C; Luo J; Zeng Y; Zhang C; Li Q; Zhang Y; Xu W; Zhang T; Huang P
ACS Appl Mater Interfaces; 2021 Aug; 13(32):38114-38126. PubMed ID: 34357760
[TBL] [Abstract][Full Text] [Related]
18. Drug-Loaded Lipid-Coated Hybrid Organic-Inorganic "Stealth" Nanoparticles for Cancer Therapy.
Li X; Salzano G; Qiu J; Menard M; Berg K; Theodossiou T; Ladavière C; Gref R
Front Bioeng Biotechnol; 2020; 8():1027. PubMed ID: 33042960
[TBL] [Abstract][Full Text] [Related]
19. Two-Dimensional Metal-Organic Framework/Enzyme Hybrid Nanocatalyst as a Benign and Self-Activated Cascade Reagent for in Vivo Wound Healing.
Liu X; Yan Z; Zhang Y; Liu Z; Sun Y; Ren J; Qu X
ACS Nano; 2019 May; 13(5):5222-5230. PubMed ID: 31002497
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in Cu(II)/Cu(I)-MOFs based nano-platforms for developing new nano-medicines.
Sun Y; Jiang X; Liu Y; Liu D; Chen C; Lu C; Zhuang S; Kumar A; Liu J
J Inorg Biochem; 2021 Dec; 225():111599. PubMed ID: 34507123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
